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The need fora speciﬁc risk score systemfor infective endocarditis (IE) surgery hasbeen previously claimed. In a single-center pilot
study, preliminary to future multicentric development and validation, bivariate and multivariate (logistic regression) analysis of
early postoperative mortality predictors in 440 native valve IE patients were performed. Mathematical procedures assigned scores
to the independent predictors emerged (AUC of the ROC curve: 0.88). Overall mortality was 9.1%. Six predictors were identiﬁed
and assigned scores, including age (5–13 points), renal failure (5), NYHA class IV (9), critical preoperative state (11), lack of
preoperative attainment of blood culture negativity (5), perivalvular involvement (5). Four risk classes were drawn ranging from
“very low risk” (≤5 points, mean predicted mortality 1%), and to “very high risk” (≥20 points, 43% mortality). IE-speciﬁc risk
stratiﬁcation models are both needed, as disease-speciﬁc factors (e.g., cultures, abscess), beside the generic ones (e.g., age, renal
impairment) aﬀect mortality, and feasible.
1.Introduction
Surgical prognosis of infective endocarditis (IE) is hetero-
geneous, in as much as diﬀerent microbiologic etiologies;
baselineconditionsandmodesofpresentationtosurgerycan
combinevariablytogiverisetodisparatepatientproﬁleswith
diﬀerent risk of postoperative mortality. Likely owing to this
heterogeneity, a number of retrospective studies have yielded
discordant results in terms of impact and timing of surgery
[1–3].
In this scenario, prognostic stratiﬁcation tools could be
helpful both in case-by-case clinical practice, to assist in the
decision on surgical indication, and in clinical research, to
warrant homogeneity of cohorts in comparative studies and
to identify unique patient proﬁles in whom to assess surgical
outcomes [1–3]. A speciﬁc prognostic tool for IE is not cur-
rently in use; thus, perioperative risk prediction for IE repre-
sents an area still open to further improvement [4, 5]. Diﬀer-
entscoringsystems areusedincardiacsurgery forprognostic
classiﬁcation, including the additive and logistic models of
the European System for Cardiac Operative Risk Evaluation
(EuroSCORE) [6], the Society of Thoracic Surgeons (STS)
scores [7], and the New York models [8]. However, none
of them is speciﬁc for the setting of endocarditis, although
surgery for endocarditis is not comparable to other cardiac
procedures in terms of postoperative morbidity and mortal-
ity risks [5]. The ﬁrst large study addressing the need for a
dedicated stratiﬁcation method has beenvery recently issued
bytheDukeUniversitygroup,who substantially performed a
recalibration of the STS system in a selected population with
IE [9].
O n ea i mo ft h ep r e s e n ts t u d yw a st ov e r i f yw h e t h e rd i s -
ease-speciﬁc determinants of mortality risk following native
valve IE surgery could be detected from a review of our
experience. Another aim was to assess the methodological
feasibility ofdevelopinga speciﬁc risk score system for native
valve IE, as a preliminary study, foreseeing future application2 The Scientiﬁc World Journal
of the method in a more statistically powered multicentric
study.
2.Materialsand Methods
2.1. Patient Series and Variables. A dedicated database was
prospectively ﬁlled in from January 1980 through December
2009 to save the data concerning 591 operations for infective
endocarditis performed at our tertiary referral Institution.
Forsake of sample homogeneity with respect to preoperative
conditions and risk of postoperative mortality [10], only
cases of IE of native valves were considered for the present
analysis, excluding 151 cases of prosthetic IE. Thus, 440
patients constituted the study population (mean age 49 ± 16
years, range 8–87, 72% males).
Preoperative variables included in the database con-
cerned activity phase (active/healed endocarditis, where
“active” is deﬁned as endocarditis still under antibiotic ther-
apy or with positive blood cultures or fever, leukocytosis,
raised inﬂammation markers); valve (or valves) involved;
type of anatomic lesion (vegetation, cusp perforation, or
perivalvular involvement, including abscesses and ﬁstulae);
risk factors for endocarditis development (drug abuse, im-
munodeﬁciency, congenital or acquired valve anomalies,
dialysis); comorbidities (renal failure or serum creatinine
>2mg/dL at admission, chronic liver disease, diabetes,
hypertension, chronic pulmonary disease); basic echocar-
diography parameters (left ventricle dimensions, septum
thickness, ejection fraction); clinical presentation (including
New York Heart Association (NYHA) functional class, pre-
vious embolisms, septic/cardiogenic shock, preoperative
ventilatory support, either invasive or noninvasive); surgical
indication criteria (elective, urgent, or on emergency). From
January 2000 (when the EuroSCORE was implemented in
the Institutional protocols) to the end of the data collection
period, the logistic and additive EuroSCORE values had
been recorded for each patient as well, along with the
relative criteria. The following microbiology variables from
the database were used for the present analysis: preoperative
blood cultures categorized as “ever positive” or “always neg-
ative” (data available for 95% patients); positivity/negativity
ofthelatestbloodculturebeforeoperation;microbialspecies
isolated from blood. Included in the database but not in the
predicting models for mortality were positivity/negativity of
valve tissue cultures (data available for 97.7% patients) and
microbial species isolated postoperatively from the surgical
specimens.
Surgical methods remained substantially the same
throughoutthe study period. Standard cardiopulmonary by-
pass methods were always employed, protecting the heart by
means of cold crystalloid cardioplegia in all cases.
Among the recorded postoperative outcomes, postoper-
ative mortality (deﬁned as 30-day deathorin-hospital death,
if the patient had a hospital stay longer than 30 days before
dying), cause of death, postoperative evidence of non-erad-
ication (positive blood cultures, fever, leukocytosis, inﬂam-
matory biomarkers including erythrosedimentation rate and
C-reactive protein) were considered for the present study,
whereas follow-up datawere notused.To correctforpossible
time eﬀects, a further variable was included in all analyses,
indicating the decade of operation (1980–1989, 1990–1999,
or 2000–2009). The present study was approved by the local
Institutional Ethics Committee.
2.2. Statistical Methods for Score System Development. To
assess the predictors of mortality and to experiment with the
process of scoring system development, the above series was
analyzed through a 3-step procedure, employing the SPSS
ver13.0 statistical software (SPSS, Chicago, Ill, USA).
The ﬁrst step consisted of the identiﬁcation of the
preoperative variables signiﬁcantly associated, in bivariate
analysis, withpostoperativemortality.Thet-testwasusedfor
comparison of continuous variables and the χ2 test, or Fis-
cher’s exact test when appropriate, for categorical variables.
Age was also categorized in 10-year classes. Signiﬁcance was
considered for a P value of at least 0.05.
Variables resulting signiﬁcantly associated with mortality
were then entered (second step) in a multivariable logistic
regression model predicting postoperative mortality. The
Hosmer and Lemeshow test and the receiver operating
characteristic (ROC) curve were used to estimate the ﬁt and
discrimination of the model. In this second step, the pre-
dicted probability of death of each patient was also yielded
by the regression model and saved as a separate variable.
According to a previously validated method [8, 11], the
third step (risk index development) consisted of deﬁning
a constant, corresponding to the unitary risk in the score
system: this was obtained by multiplying the coeﬃcient
estimate of the age variable by half the width of the age
classes, that is, 0.041 × 5y e a r s= 0.205. The coeﬃcient
for each identiﬁed risk factor was then divided by the
unitary score (0.205) and rounded to the closest integer to
be transformed into risk points (e.g., for the renal failure
variable the coeﬃcient was 1.076: 1.076/0.205 = 5.248 ≈ 5
points). The total risk score for each patient was then
calculatedasthesumofthepointsforeachriskfactorpresent
in that patient. The correlation between total scores and
predicted probability of death according to the regression
model was assessed through Spearman’s test, and it reached
a rho value of 0.94 (P<0.001).
For the subpopulation in which the EuroSCORE was
prospectively calculated (252 patients operated on between
2000and2010),thecorrelationbetweentheEuroSCOREand
our system was evaluated by means of Kendall’s tau corre-
lation test (after preliminary assessment of nonnormality of
distributions). The discriminating abilitiesof thetwomodels
were reevaluated in this subset by estimating the respective
areas under the ROC curves.
3.Results
3.1. Baseline Features and Clinical Outcome. Endocarditis
wasinactivephasein365(83%)patients,healedin75.Endo-
carditis involved the native aortic valve alone in 200 (45.5%)
cases, the mitral valve in 110 (2 5 % ) ,t h et r i c u s p i dv a l v ei n4 1
(9.3%), the pulmonary valve in 3 (0.7%), whereas multipleThe Scientiﬁc World Journal 3
valve involvement was observed in the remaining 86 cases
(the most frequent association being mitral plus aortic site,
71 patients, 16%). Among risk factors, diabetes was present
in 51 patients (11.6%), intravenous drug abuse in 58
(13.2%), and renal failure (either acute or chronic) in 60
(13.6%).Surgerywasindicatedonanemergencybasis, either
for unresponsive septic state, severe cardiac failure, or severe
systemic embolic risk, in 55 patients (12.5%), on urgency
basis in 352 patients (80%), and only 33 patients were
operated on electively.
Microorganisms identiﬁed in culture-positive cases
(64.5%) included streptococcal spp. (43%), staphylococcal
spp. (37%), gram negative spp. (14%), and others (6%, in-
cluding, mainly, enterococci, fungi, corynebacteria, and pol-
ymicrobial etiologies).
Valve repair was performed in 48 patients (11%) in
whom the valve tissue was judged not extensively involved
by the infective process.
Overall postoperative mortality was 9.1% (40 patients).
A cardiac cause of death (including low output syndrome,
intractablearrhythmia, pulmonaryembolism)wasidentiﬁed
in 20 patients; othercauses ofmortality includedmultiorgan
failure (9 patients), persistence of septic shock (6 patients),
and postoperative pneumonia (5 patients).
3.2. Development of the Prognostic Classiﬁcation System. Bi-
variateanalysisresultsaredisplayedinTable1.Onlyvariables
withP value < 0.05were introduced in the logistic regression
model. The results ofthemultivariable analysis are presented
in Table 2. Six independent predictors of mortality emerged
in this series: age, preoperative renal failure, NYHA class IV,
preoperative mechanical ventilatory assistance, perivalvular
involvement (abscess or mycotic aneurysm) and positivity of
the latest blood culture before operation. The P value for the
Hosmer and Lemeshow test was 0.52, and the area under
the ROC curve was 0.88 (95% CI 0.82–0.93), indicating
satisfying goodness of ﬁt and discriminating ability of the
model (Figure 1(a)).
Through the aforementioned method, scores were as-
signed to these variables, as depicted in Table 2.T h es c a t t e r -
plot of the relation between predicted death probability and
patients’ total scores allowed for identiﬁcation of risk classes:
in particular, we referred to the upper limit of predicted
mortality ranges with any given total score, following a cri-
terion of clinical meaningfulness (Figure 2). Thus, the
following prognostic groups were deﬁned: total score = 0o r
5 (class 1, “very low risk”); 7–13 (class 2, “low risk”); 14–
19 (class 3, “high risk”); ≥20 (class 4, “very high risk”). The
four classes corresponded to the mean predicted mortality
rates reported in Table 3 (P<0.001 for all post-hoc com-
parisons with one-way analysis of variance and Bonferroni’s
correction). Observed mortality was 0.7% in class 1 (1/140
patients), 2.2% in class 2 (4/179 patients), 18% in class
3 (12/67 patients), and 42.6% in class 4 (23/54 patients)
(P<0.001). Comparisons between the four classes for
clinically relevant variables (Table 3) showed that, beside the
identiﬁed independent predictors, other variables resulted to
signiﬁcantly diﬀer between risk classes, for example, diabetes
and emergency.
Table 1: Bivariate correlates of hospital (30-day) mortality.
Deaths (n/N;% ) P
Age: <40 years 2/71 (2.8%)
40–49 years 6/146 (4.1%)
50–59 years 7/91 (7.7%) <0.001
60–69 years 10/81 (12.3%)
70–79 years 13/45 (28.9%)
≥80 years 2/6 (33.3%)
Sex (female) 16/124 (12.9%) 0.10
IE Phase (active) 37/365 (10.1%) 0.09
Site: Aortic 14/200 (7%)
Mitral 9/110 (8.2%)
Tricuspid 6/41 (14.6%) 0.27
Mitroaortic 10/71 (14.1%)
Other 1/18 (5.6%)
Drug abuse 2/58 (3.4%) 0.07
Diabetes 9/51 (17.6%) 0.03
Preop. renal failure 15/60 (25%) <0.001
Previous cardiac surgery 4/38 (10.5%) 0.17
Ejection fraction <50% 9/49 (18.4%) 0.03
NYHA class: I, II, or III 14/350 (4.0%) <0.001
IV 18/70 (25.7%)
Pre-op. ventilatory support 8/20 (40%) <0.001
Previous embolism 12/142 (8.5%) 0.86
Cerebral embolism 7/59 (11.9%) 0.46
Emergency operation 17/55 (30.9%) <0.001
Positive latest preop. blood
culture 15/76 (19.7%) 0.001
Isolated microbial agent:
Staphylococcal spp. 7/106 (6.6%)
Streptococcal spp. 8/123 (6.5%) 0.007
Others1 12/55 (22%)
Perivalvular involvement 16/70 (22.9%) <0.001
Valve repair 2/48 (4.2%) 0.38
Decade: 1980–1990 8/77 (10.4%)
0.33 1990–1999 11/139 (7.9%)
2000–2009 21/224 (9.4%)
1“Others” here includes gram-negative, corynebacteria, enterococci, fungi,
multimicrobial isolates (when introduced in analysis each of these groups
constituted a separate modality of the “microbialagent” variable).
In the subpopulation (n = 252) operated on from 2000
to 2010, correlations between the additive EuroSCORE and
our score, as well as between logistic EuroSCORE and pre-
dicted probability derived from our logistic regression, were
statistically signiﬁcant, but the tau coeﬃcients indicated that
colinearity was not so high (0.47 both, P<0.001). When
the ROC curve analysis was repeated in this subgroup, it
conﬁrmedthegooddiscriminationpowerofourmodel,with
an AUC of 0.91 (95% CI 0.85–0.97), while the AUC was 0.84
(95% CI 0.77–0.91) for the logistic EuroSCORE in the same
subgroup (Figure 1(b)).4 The Scientiﬁc World Journal
Table 2: Independent preoperative predictors of mortality (logistic
regression analysis) and the deriving scoring system for mortality
prediction in native valve IE.
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2Patients admitted to the Cardiac Surgery Department on mechanical ven-
tilation(intubated) or requiring ventilatory support by noninvasive ventila-
tion during preoperative stay (generally for poor hemodynamic conditions
and/or pulmonary edema).
3This variable identiﬁed operation without possibility of previous attain-
ment of negative cultures by antibiotic therapy (latest culture had always
been performed within 5 to 7 days preoperatively).
4Either annular abscess or aortocavitary ﬁstula.
4.Discussion
4.1. The Need for a Dedicated Score System. Methods of risk
stratiﬁcation in cardiac surgery serve to provide the patients
withpersonalizedprognosisprediction,toinformtheclinical
decision-making process, and to establish benchmarks for
outcomes estimation and comparison.
The present study, consistently with a number of previ-
ous analyses [12–15], showed that 2 out of the 6 most signif-
icant independent predictors of postoperative death in 440
endocarditis surgery patients were speciﬁc of the IE setting,
that is, microbiology- or infection-related, and not included
in the most commonly employed prognostic systems.
Until recently, only a small Brazilian study including 186
patients had tried to derive a score system from a mixed
native and prosthetic endocarditis cohort [12]: single-center
design and small numbers prevent direct wider applicability
of that system, as well as ours. The aforementioned Duke’s
study by Gaca and colleagues, conversely, was based on
more than 13,600 IE patients from the STS database [9]:
the multicentric design and the large sample size provided
optimal statistical strength and applicability at least over all
North America. However, STS entries do not include micro-
biological (cultures, species) and anatomical (vegetations,
abscess) data, which; however, play an important prognostic
role [12–15]. Moreover, the Duke study considered native
and prosthetic valve IE together [9], whereas prosthetic valve
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Figure 1: (a) Receiver-operator characteristic (ROC) curve for our
logistic regression model developed from the analysis of 440 native
v a l v eI Ep a t i e n t s :n o t et h eh i g hv a l u eo ft h eA U C ,a l s oc o m p a r e d
to the one reported in the EuroSCORE development study (0.78
[8]); (b) ROC curves for our logistic regression model and the
logistic EuroSCORE in the subpopulation (2000–2010) for whom
EuroSCORE data were available; AUC: area under the curve.
endocarditis is a deﬁnitely distinct condition, with a consid-
erably higher mortality and, even more importantly when
prognostic stratiﬁcation is concerned, with markedly diﬀer-
ent preoperative features [10]. Drawing a parallel, the widelyThe Scientiﬁc World Journal 5


































Very low risk Low risk High risk Very high risk
Figure 2: Scatterplot of predicted probability of postoperative 30-
day death (y-axis, depicted with exponential scale) against total
score per patient (x-axis). Horizontal dotted lines indicate the
levels of death probability corresponding to the average observed
mortality (9.1%), half of it (4.55%), and 3-fold higher mortality
(27.3%). The four prognostic classes (thresholds indicated by
vertical dottedlines)were identiﬁedby(1)thescorescorresponding
to a predicted mortality not exceeding 4.55% (0 or 5 points); (2)
the score range including cases with a predicted mortality above
4.55%, but none beyond 9.1% (7–13 points); (3) the score range
whereby predicted mortalitiesexceeded 9.1%;however,withnocase
over 27.3% (14–19 points); (4) the scores associated with predicted
mortality range exceeding 27.3% (score ≥20).
employed EuroSCORE model for 30-day mortality predic-
tion in cardiac surgery was ﬁrst developedfrom a population
ofmore than19000patients,predominantlyundergoingcor-
onary artery bypass grafting [6]. Its performance in peculiar
subsetsofpatients,forexample,inthoracicaortasurgery,has
been demonstrated to be poorer, unless the system is modi-
ﬁedtoincludeadditionaldisease-speciﬁc variables[16].Sim-
ilarly, IE-speciﬁc factors should probably be integrated into
the score system developed by Gaca, or it could be com-
bined with a complementary system accounting for them, to
improve prediction (a C statistic of nearly 0.76 was reported
[9]).
In the present study, including only native valve IE, we
noticed that mortality in a predominant portion (risk classes
1 and 2, accounting together for 72%) of the whole series
wasnot higherthan thatcommonlyobservedfollowing valve
replacement for noninfectious disease (5 deaths, 1.6%). A
distinct smaller patient group, representing the remaining
28% of our study population, showed a signiﬁcantly higher
mortality (approaching 29%),leading to an overall mortality
of9.1%.ThissuggeststhatnativeIEshouldnotbeconsidered
as ahigh-risk conditioninabsoluteterms;more appropriate-
ly, subsets of patients with clearly diﬀerent prognosis, owing
to diﬀerencesin variables missing inthe EuroSCORE orSTS,
should be otherwise distinguished. An even greater prognos-
tic variability would have been found if also prosthetic endo-
carditishadbeenincluded.Notably,theEuroSCORE[6],STS
score for valve surgery [7] ,a n dD u k e ’ ss c o r ef o rI E[ 9]o n l y
include one variable related to this speciﬁc setting, namely,
the “active” endocarditis variable, whereas in the IE patient
population, according to both our and others’ studies [12–
14], this does not result to independently predict mortality.
4.2. The Criteria in Our Score System. The factors included
by our score system covered all three prognostically relevant
aspects of patient presentation, that is, the baseline features,
the degree of hemodynamic impairment, and the character-
istics of the infectious process.
Amongbaselineconditions,ageandrenalfailurewerethe
onlyfactorsindependentlypredictingmortality inthisseries.
It is important to underscore the diﬀerent categorization of
the age variable between our score and the traditional sys-
tems:intheEuroSCOREathresholdof60years,intheSTSof
55, marks the increase of risk compared to the younger ages;
however, due to the peculiar epidemiology of native valve IE
[2, 4, 12, 15], those higher thresholds may leave the prognos-
tic diﬀerences between lower age groups unrecognized.
The signiﬁcance of renal failure as an independent pre-
dictor of mortality is not unique to the IE setting; never-
theless, it emerged in several previous reports on this topic
[9,13,17]suggestingthat itsstatistical weight as aprognostic
factor may be even greater for IE operations than for general
cardiac surgery. In fact, highest-risk patients often reach
surgery aftera more orless acutehemodynamic impairment,
with possible renal hypoperfusion, and/orfollowing a course
ofaggressivemedicaltherapy,possiblyincludingnephrotoxic
antibiotics. Thus, renal failure may represent not only a
predisposing factor for potentially lethal postoperative com-
plications but also an important marker of high-risk status
in IE. No other baseline conditions resulted to signiﬁcantly
predict mortality in our multivariable logistic regression;
notably the analysis was also reperformed in the 2000–2010
subset adding the EuroSCORE value as a covariate (data not
shown); however, the same 6 determinants resulted and the
EuroSCORE did not reach signiﬁcance as a predictor.
Among hemodynamics-related factors, only NYHA class
IV, instead of other imaging (e.g., low ejection fraction) or
clinical factors (e.g., preoperative inotropes), was a signif-
icant prognostic predictor of 30-day mortality. This result
is consistent with the study by Hasbun and colleagues [4],
proposing a risk classiﬁcation method for medically or sur-
gically treated complicated left-sided native IE: “congestive
heart failure” was among the signiﬁcant predictors in their
scoring system, deﬁned basically through physical ﬁndings,
such as rales on examination and dyspnea at rest.
Patientswith preoperativeventilatory support inthe pre-
sent study were generally those with the most compromised
hemodynamics: the indication to mechanical ventilation/
support was pulmonary edema in60%cases, septicshock, or6 The Scientiﬁc World Journal
Table 3: Deﬁnition of the 4 risk groups according to total score and comparisons in terms of clinically relevant variables.
Class 1 Class 2 Class 3 Class 4 P
Total score range 0–5 7–131 14–19 ≥20
Mean predicted mortality 1 ±0.7% 3.7 ± 1.6% 12 ± 5% 43 ± 18%
Age (years) 34 ± 95 5 ±13 52 ±17 64 ±11 <0.001
Sex (female) 30% 20% 37% 39% 0.06
Active IE 81% 79% 91% 89% 0.08
Site: Aortic 47% 44% 51% 41%
0.03
Mitral 27% 27% 16% 22%
Tricuspid 6% 11% 9% 9%
Mitroaortic 11% 16% 21% 26%
O t h e r 9 % 2 %3 %2 %
NYHA class IV — 1.7% 52% 59% <0.001
Diabetes 3% 12% 22% 18% <0.001
Renal failure 4% 8% 27% 39% <0.001
Period: before 2000 39% 40% 14% 7% 0.003
2000–2010 26% 42% 16% 16%
Positive latest preop. culture 5% 17% 19% 44% <0.001
Perivalvular involvement 4% 12% 27% 44% <0.001
Preop. ventilatory support — — 6% 30% <0.001
Emergency 0.7% 4% 22% 59% <0.001
Infection persistence postop. 2% 2% 9% 29% <0.001
1Note that the 6-point score cannot be obtained by any sum of scores in this system.
both in the others. Notably, when this factor entered the
multivariable logistic model, it suppressed the signiﬁcance
of the “emergency” factor, since all preoperatively intubated
patients were operated on an emergency basis. Therefore,
the importance of this factor in our system is consistent
with what was found by the Duke study [9], whereby the
preoperative hemodynamic condition of the patient was the
greatest predictor of mortality.
With regard to microbiological and infection-related pa-
rameters, in our bivariate analysis, partly in accordance with
the study by Hasbun and coworkers [4], an etiological agent
diﬀerent from Streptococcus and Staphylococcus was associ-
ated with higher mortality: this is also plausible according to
clinical experience and published literature [18]. However,
this factor did not emerge as an independent determinant in
logistic regression. A stronger microbiological predictor was
the positivity of the latest blood culture before operation,
which was often a marker of operation being performed
before completion of an adequate course of antibiotic
therapy, generally because surgery was brought forward for
severe cardiac failure or embolic risk. In a post hoc analysis
(data not shown), this was signiﬁcantly associated with
positive valve culture, staphylococcal etiology, emergency
operation, large vegetations, and persistent signs of infection
in the early postoperative period: this latter could be
related to undisclosed extracardiac foci and/or particularly
high local bacterial load leading to clinically evident blood
dissemination following surgical manipulation.
Finally, perivalvular involvement has already been con-
troversially discussed as a possible risk factor for mortality
following IE surgery [13, 19]. Indeed, some studies con-
cluded that periannular extension of the infection does not
entail a higher risk; however, those were not purely surgical
seriesbutalsoincludedmedicallytreatedpatients[19].Thus,
the perivalvular factor might represent not only a marker of
more virulent microbial agent but also a predictor of more
complex surgery, expectedly implying extensive reconstruc-
tion procedures and longer cardio-pulmonary and cross-
clamp times, which ultimately increase early mortality risk
[20]. As an alternative interpretation, echocardiography can
yield a false diagnosis of abscess or even miss its detection,
introducing an unquantiﬁable bias in the analysis of the
prognostic value of perivalvular involvement in mixed medi-
cal/surgicalIEseries.Conversely,surgicalinspection canpro-
vide the deﬁnitive conﬁrmation of a true abscess: in the
present series, 0.2% of patients had a false preoperative
diagnosis of abscess, and a preoperatively unseen abscess was
detected in 2% at surgery.
4.3. Study Limitations. The main obvious limitation of the
present study is the small patient sample. Single-center
design ensured uniformity of methods in the perioperative
period, which was essential for a study concerning postoper-
ative mortality prediction. However, this limitation restricts
the value of the present study to a hypothesis-generating
analysis, demonstrating the need to combine more soundlyThe Scientiﬁc World Journal 7
developed predictive systems, like the score introduced by
Gaca et al. [11], with more speciﬁc subscores including vari-
ables unique to IE. Our score may serve to this scope, pro-
vided that it will be validated in other larger series, possibly
in multicentric design. Since the preoperative features of our
patient population, the overall mortality and the predictors
emerging from the analysis did not diﬀer importantly from
those of many other centers [4, 12–15, 17–20], we believe
that our analysis was not aﬀected by signiﬁcant selection,
referral, or treatment biases and that our study population is
well representative of the real scenario of native valve IE: this
maybe agoodpremise intheperspective offutureexpansion
of the present study in multicentric design. Unfortunately,
like many centers in our Country, we have been using the
EuroSCORE system, since its introduction, for routine risk
prediction in all our surgical practice: this system has been
morerecentlycriticizedas notadequatetothesettingofvalve
surgery [21]; however a retrospective estimation of the STS
score in this series was not possible due to the lack of the
relevant data, not prospectively collected. Anotherlimitation
(especially to the homogeneity of the population) was the
inclusion of a minority of patients with healed endocarditis
(17%),namely,patientshavingdiscontinuedantibioticsafter
the clinical evidence of no activity of the infection (no
fever,negative bloodcultures):thissmall subsetwasincluded
notwithstanding its expected lower mortality, as a “control”
subgroup, to calibrate the reliability of the overall series, as
well as to rule out the independent eﬀect of some factors
(such as vegetations, for example, which were present at
surgery in 46% cases of clinically healed endocarditis) on the
study endpoint. Similarly, others have included even much
greater proportions (>48%) of healed IE patients in their
analysis of mortality predictors [11].
5.Conclusions
In the present study we found that IE-speciﬁc factors (e.g.,
cultures, abscess), beside the generic ones (e.g., age, renal
impairment, poorhemodynamic conditions),independently
predicted mortality following native valve endocarditis
surgery. We also ascertained the feasibility of a dedicated
stratiﬁcation tool:oursystemwill becalibratedandvalidated
in multicentric series in the next future. Provided successful
validation on a larger scale, adjunctive risk-stratiﬁcation
tools like the model developed in this study could be used
along with the EuroSCORE or the STS score, to more specif-
ically deﬁne individual IE patient’s risk proﬁle.
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